drugset / Trial / NCT01421121
Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
A randomized, placebo-controlled, double-blind clinical trial is to evaluate the safety and immunogenicity of a new inactivated EV71 vaccine developed by Sinovac Biotech CO., LTD.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-09
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EV71 vaccine | Vaccine | 100 iu | — |
| Subject | EV71 vaccine | Vaccine | 200 iu | — |
| Subject | EV71 vaccine | Vaccine | 400 iu | — |